Effect of pemafibrate on liver enzymes and shear wave velocity in non-alcoholic fatty liver disease patients

BACKGROUND/AIMS: Pemafibrate is a selective peroxisome proliferator-activated receptor α modulator that improves serum alanine aminotransferase (ALT) in dyslipidemia patients. Pemafibrate was reported to reduce ALT in non-alcoholic fatty liver disease (NAFLD) patients, but efficacy was not clearly e...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugimoto, Ryosuke, Iwasa, Motoh, Eguchi, Akiko, Tamai, Yasuyuki, Shigefuku, Ryuta, Fujiwara, Naoto, Tanaka, Hideaki, Kobayashi, Yoshinao, Ikoma, Jiro, Kaito, Masahiko, Nakagawa, Hayato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941328/
https://www.ncbi.nlm.nih.gov/pubmed/36824614
http://dx.doi.org/10.3389/fmed.2023.1073025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941328/
https://www.ncbi.nlm.nih.gov/pubmed/36824614
http://dx.doi.org/10.3389/fmed.2023.1073025

Ejemplares similares